
Opinion|Videos|October 14, 2024
Understanding Prostate-Specific Antigen (PSA) Testing
Key Takeaways
- Prostate cancer screening is essential for early detection, especially in high-risk groups like men over 50, African Americans, and those with a family history.
- Routine screening, including PSA tests and digital rectal exams, aids in identifying cancer at an early, treatable stage.
Panelists discuss how the PSA test is conducted and interpreted, and clarify the definitions of high-risk and advanced prostate cancer types, including their implications for prognosis and subsequent treatment decisions.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- What is a PSA test and how is it performed? How do PSA levels guide next steps?
- Can you explain what high-risk and advanced prostate cancer are, eg, (non-metastatic castration-sensitive prostate cancer (nmCSPC) with BRC at high risk for metastases, castration-resistant prostate cancer (CRPC), and metastatic CSPC (mCSPC)? What is the prognosis for patients diagnosed with advanced disease?
Advertisement
Related to this article

Up to 40% of patients with classic hairy cell leukemia relapse within 10 to 15 years. An NIH researcher explains how adding Rituxan up front may help.

Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.

Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.

Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.

In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.

Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.

Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
3
Weight Loss With Pancreatic Cancer: Why It Happens and What Helps
4
Glioblastoma Patients Can Request Genomic Testing on Their Tumor Tissue
5

